Dr. Gregory Moore
Claim this profileMonash Health, Monash Medical Centre
Studies Crohn's Disease
Studies Inflammatory Bowel Disease
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Gregory Moore is currently running
Vedolizumab
for Crohn's Disease
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with the vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no signs of inflammation. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive either a high dose or low dose of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 36 criteria
Vedolizumab
for Ulcerative Colitis and Crohn's Disease
The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Recruiting3 awards Phase 3
More about Gregory Moore
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Gregory Moore has experience with
- Vedolizumab
- Gepotidacin
- Nitrofurantoin
- Abbott's Neurostimulation Systems
- No Treatment
- Vedolizumab IV
Breakdown of trials Gregory Moore has run
Crohn's Disease
Inflammatory Bowel Disease
Ulcerative Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Moore specialize in?
Gregory Moore focuses on Crohn's Disease and Inflammatory Bowel Disease. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Gregory Moore currently recruiting for clinical trials?
Yes, Gregory Moore is currently recruiting for 2 clinical trials in Clayton Victoria. If you're interested in participating, you should apply.
Are there any treatments that Gregory Moore has studied deeply?
Yes, Gregory Moore has studied treatments such as Vedolizumab, Gepotidacin, Nitrofurantoin.
What is the best way to schedule an appointment with Gregory Moore?
Apply for one of the trials that Gregory Moore is conducting.
What is the office address of Gregory Moore?
The office of Gregory Moore is located at: Monash Health, Monash Medical Centre, Clayton, Victoria 3168 Australia. This is the address for their practice at the Monash Health, Monash Medical Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.